Abstract
Many nonsteroidal anti-inflammatory drugs (NSAIDs) have been developed and marketed since the discovery of aspirin in 1897. These agents frequently are prescribed for the management of arthritis symptoms, including joint pain and inflammation. Despite their therapeutic benefits, NSAIDs are known to be associated with serious gastrointestinal side effects, including ulceration, hemorrhage, and perforation. Thus, one of the main reasons for the continued development of new NSAIDs is the hope of of finding a drug with improved efficacy or safety. To date, clinically meaningful differences in the therapeutic efficacy of different NSAIDs have not been reported. However, recent studies have indicated that differences do exist in the gastrointestinal safety profiles of individual NSAIDs. This article reviews these studies and discusses strategies for NSAID use based on efficacy, safety, and cost issues.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.